Because T cell infiltration correlates with the response of tumor to immune checkpoint inhibitiors30, R1 may be more likely to respond to immune checkpoint blockade with inhibitors of programmed cell death 1 (PD1) or PD-L1 such as atezolizumab. Here, PDCD1 is linked to neoplasm.